Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | ALIEV, GJUMRAKCH |
| Género | - |
| Área Principal WOS | Oncology; |
| Afiliación Principal | University Of Atlanta |
| ORCID
|
0000-0001-7373-3182 |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| WOS | #Pub |
|---|---|
| Oncology | 1 |
| Scopus | #Pub |
|---|---|
| Pharmacology | 1 |
| Oncology | 1 |
| Cancer Research | 1 |
| Drug Discovery | 1 |
| SciELO | #Pub |
|---|
| Institución | # Pub |
|---|---|
| University Of Atlanta | 45 |
| Univ Atlanta | 43 |
| Gally International Biomedical Research Consulting Llc | 41 |
| Institute Of Physiologically Active Compounds Of The Russian Academy Of Science | 40 |
| Russian Acad Sci | 38 |
| Gally Int Biomed Res Consulting Llc | 36 |
| "Gally" International Biomedical Research Consulting Llc | 8 |
| Gally Int Biomed Res Inst Inc | 4 |
| Gally Int Biomed Res & Consulting Llc | 3 |
| Gally Int Biomed Res Llc | 2 |
| Univ Atlanta | 1 |
| Gally Int Biomed Res Consulting Llc | 1 |
| Pontificia Universidad Javeriana | 1 |
| Atlanta | 1 |
| Pontificia Univ Javeriana | 1 |
| Sechenov First Moscow State Medical University | 1 |
| Universidad Autónoma De Chile | 1 |
| Año | Firma | Institución (Incites asoc.) | H Index | Average Percentile | Impact Citation | Impact Relative World | Impact Journal Normalized Citation | Impact Category Normalized Citation | Percentage Cited | Percentage Top 1 | Percentage Top 10 | Percentage Journal Q1 | Percentage Journal Q2 | Percentage Journal Q3 | Percentage Journal Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | Aliev, Gjumrakch | Universidad Autonoma de Chile | 1.0 | 59.1 | 1.0 | 0.1 | 0.6 | 0.5 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 0.0 |
| Título | Año | Citas | Tipo | Revista | Indexada |
|---|---|---|---|---|---|
| Chemosensitizing Activity Of Histone Deacetylases Inhibitory Cyclic Hydroxamic Acids For Combination Chemotherapy Of Lymphatic Leukemia | 2018 | 5 | artículo de investigación | Current Cancer Drug Targets | WoS Scopus |
| Palabra Clave | #Pub |
|---|---|
| chemosensitizing property | 1 |
| combination chemotherapy | 1 |
| hdac inhibitory activity | 1 |
| histone deacetylases | 1 |
| hydroxamic acid | 1 |
| lymphatic leukemia | 1 |
| nitric-oxide | 1 |